A detailed history of Sg Americas Securities, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,951 shares of MDGL stock, worth $677,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,951
Holding current value
$677,874
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$212.22 - $292.96 $414,041 - $571,564
1,951 New
1,951 $414,000
Q1 2024

May 06, 2024

BUY
$171.37 - $283.23 $230,835 - $381,510
1,347 New
1,347 $360,000
Q3 2023

Oct 13, 2023

BUY
$146.04 - $225.78 $647,833 - $1 Million
4,436 New
4,436 $648,000
Q1 2023

Apr 28, 2023

BUY
$231.06 - $307.08 $1.39 Million - $1.85 Million
6,021 Added 541.94%
7,132 $1.73 Million
Q4 2022

Feb 02, 2023

SELL
$58.39 - $296.54 $431,326 - $2.19 Million
-7,387 Reduced 86.93%
1,111 $322,000
Q3 2022

Oct 31, 2022

SELL
$60.57 - $79.51 $663,059 - $870,395
-10,947 Reduced 56.3%
8,498 $552,000
Q2 2022

Jul 29, 2022

SELL
$58.04 - $100.2 $721,088 - $1.24 Million
-12,424 Reduced 38.98%
19,445 $1.39 Million
Q1 2022

Apr 29, 2022

BUY
$55.89 - $101.89 $1 Million - $1.83 Million
17,968 Added 129.26%
31,869 $3.13 Million
Q4 2021

Feb 07, 2022

SELL
$72.34 - $95.09 $1.43 Million - $1.88 Million
-19,784 Reduced 58.73%
13,901 $1.18 Million
Q3 2021

Nov 01, 2021

BUY
$78.35 - $105.02 $712,514 - $955,051
9,094 Added 36.98%
33,685 $2.69 Million
Q2 2021

Aug 12, 2021

SELL
$97.2 - $137.59 $187,693 - $265,686
-1,931 Reduced 7.28%
24,591 $2.4 Million
Q1 2021

May 13, 2021

SELL
$108.54 - $125.2 $163,244 - $188,300
-1,504 Reduced 5.37%
26,522 $3.1 Million
Q4 2020

Feb 04, 2021

BUY
$110.06 - $133.7 $2.4 Million - $2.92 Million
21,806 Added 350.58%
28,026 $3.12 Million
Q3 2020

Nov 09, 2020

BUY
$99.78 - $124.21 $211,932 - $263,822
2,124 Added 51.86%
6,220 $739,000
Q2 2020

Jul 20, 2020

SELL
$60.13 - $125.71 $142,387 - $297,681
-2,368 Reduced 36.63%
4,096 $464,000
Q1 2020

Apr 30, 2020

BUY
$66.76 - $93.49 $184,190 - $257,938
2,759 Added 74.47%
6,464 $432,000
Q4 2019

Jan 28, 2020

SELL
$84.28 - $118.5 $1.69 Million - $2.38 Million
-20,110 Reduced 84.44%
3,705 $338,000
Q3 2019

Nov 04, 2019

BUY
$84.4 - $106.53 $2.01 Million - $2.54 Million
23,815 New
23,815 $2.05 Million
Q3 2018

Nov 06, 2018

SELL
$207.3 - $300.31 $91,833 - $133,037
-443 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$101.55 - $313.9 $44,986 - $139,057
443 New
443 $124,000
Q1 2018

May 03, 2018

SELL
$93.35 - $149.04 $201,729 - $322,075
-2,161 Closed
0 $0
Q4 2017

Jan 24, 2018

SELL
$39.35 - $97.37 $2,793 - $6,913
-71 Reduced 3.18%
2,161 $198,000
Q3 2017

Nov 07, 2017

BUY
$15.48 - $46.19 $34,551 - $103,096
2,232
2,232 $100,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.